Comparison of Ondansetron And Metoclopramide on Reducing Nausea and Vomiting After Laparoscopic Cholecystectomy in Females

Abstract

Objective: To compare the antiemetic effects of Metoclopramide and Ondansetron in female patients undergoing laparoscopic cholecystectomy. Study Design: Quasi-experimental study. Place and Duration of Study: Department of Anesthesia, Combined Military Hospital Rawalpindi, Pakistan, Feb to Jul 2022. Methodology: Female patients aged between 15-80 years, American Society of Anesthesiologists Grade I or II planned for laparoscopic cholecystectomy were included in the study. Using non-probability consecutive sampling technique 66 patients were assigned to two Groups with 33 participants in each Group i.e., Group-A (Metoclopramide) and Group-B (Ondansetron) Group. Patients from Group-A received 10mg Metoclopramide while patients from Group-B received Ondansetron 4mg as a part of premedication. Recorded variables were nausea, vomiting and requirement of antiemetic medication at recovery, during the first 06 hours and during 06-24 hours post-operatively. Results: Mean age of the patients was 44.61±12.74 years. ASA distribution of the patients in our study revealed 28(84.8%) patients from Group-A and 26(78.8%) patients from Group-B belonged to ASA I while 05(15.2%) and 07(21.2%) were from ASA II in Group-A and Group-B respectively. Both Metoclopramide and Ondansetron were effective, however results were significant only for nausea and the requirement of antiemetic medication in post-anesthesia care unit. Conclusion: Metoclopramide and Ondansetron both are effective in reducing nausea and vomiting after laparoscopic cholecystectomy in female patients. Ondansetron is superior to Metoclopramide in the reduction of nausea postoperatively however in case of vomiting there is no significant relationship between the two drugs.

Keywords

• Anesthesia, Metoclopramide, Nausea, Ondansetron